Chronic oral pelargonidin alleviates learning and memory disturbances in streptozotocin diabetic rats

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 3, 2011, Pages 569-575

  Mirshekar, Mohammadali ^a   Roghani, Mehrdad ^a   Khalili, Mohsen ^a   Baluchnejadmojarad, Tourandokht ^b  

^a SHAHED UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cognition; Diabetic rat; Learning and memory; Oral Pelargonidin; Pelargonidin; Spatial memory

Indexed keywords

PELARGONIDIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; LEARNING; LEARNING DISORDER; LONG TERM CARE; MALE; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; NONHUMAN; PASSIVE AVOIDANCE; RAT; RECALL; SINGLE DRUG DOSE; SPATIAL MEMORY; STREPTOZOCIN DIABETES;

EID: 84856972444     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Feldman EL, Stevens MJ and Greene DA. Pathogenesis of diabetic neuropathy. Clin. Neurosci. (1997) 4: 365-370.
2. Greene DA, Stevens MJ and Feldman EL. Diabetic neuropathy: Scope of the syndrome. Am. J. Med. (1999) 30: 2S-8S.
3. Galer BS, Gianas A and Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res. Clin. Pract. (2000) 47: 123-128.
4. Ekstrom PA and Tomlinson DR. Impaired nerve regeneration in streptozotocin-diabetic rats is improved by treatment with gangliosides. Exp. Neurol. (1990) 109: 200-203.
5. Heitner J and Dickson D. Diabetics do not have increased Alzheimer type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology (1997) 49: 1306-1311.
6. Nitta A, Murai R, Suzuki N, Ito H, Nomoto H, Katoh G, Furukawa Y and Furukawa S. Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol. Teratol. (2002) 24: 695-701.
7. Biessels GJ, Smale S, Duis SE, Kamal A and Gispen WH. The effect of gamma-linolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. J. Neurol. Sci. (2001) 182: 99-106.
8. Popovic M, Biessels GJ, Isaacson RL and Gispen WH. Learning and memory in streptozotocin-induced diabetic rats in a novel spatial/object discrimination task. Behav. Brain Res. (2001) 122: 201-207.
9. Parihar MS, Chaudhary M, Shetty R and Hemnani T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J. Clin. Neurosci. (2004) 11: 397-402.
10. Flood JF, Mooradian AD and Morley JE. Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes (1990) 39: 1391-1398.
11. Laight DW, Carrier MJ and Anggard EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc. Res. (2000) 47: 457-464.
12. Ajay M and Mustafa MR. Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J. Cardiovasc. Pharmacol. (2005) 46: 36-40.
13. Cherian S and Augusti KT. Antidiabetic effects of a glycoside of leucopelargonidin isolated from Ficus bengalensis Linn. Indian J. Exp. Biol. (1993) 31: 26-9.
14. Roy M, Sen S and Chakraborti AS. Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: implication for glycation-induced hemoglobin modification. Life Sci. (2008) 82: 1102-10.
15. Dreiseitel A, Schreier P, Oehme A, Locher S, Rogler G, Piberger H, Hajak G and S and PG. Inhibition of proteasome activity by anthocyanins and anthocyanidins. Biochem. Biophys. Res. Commun. (2008) 372: 57-61.
16. Noda Y, Kaneyuki T, Mori A and Packer L. Antioxidant activities of pomegranate fruit extractand its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J. Agric. Food Chem. (2002) 50: 166-71.
17. Baydas G, Nedzvetskii VS, Nerush PA, Kirichenko SV and Yoldas T. Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus. Life Sci. (2003) 73: 1907-1916.
18. Fernyhough P, Diemel LT, Brewster WJ and Tomlinson DR. Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J. Neurochem. (1995) 64: 1231-1237.
19. Wioeniewski K, Fedosiewicz-wasiluk M, Holy ZZ, Car H and Grzeda E. Influence of NMDA, a potent agonist of glutamate receptors, on behavioral activity in 4-week streptozotocin-induced diabetic rats. Pol. J. Pharmacol. (2003) 55: 345-351.
20. Biessels GJ, van der Heide LP, Kamal A, Bleys RL and Gispen WH. Ageing and diabetes: implications for brain function. Eur. J. Pharmacol. (2002) 441: 1-14.
21. Alvarez EO, Beauquis J, Revsin Y, Banzan AM, Roig P, De Nicola AF and Saravia F. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav. Brain Res. (2009) 198: 224-30.
22. Malone JI, Hanna S, Saporta S, Mervis RF, Park CR, Chong L and Diamond DM. Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatr. Diabetes. (2008) 9: 531-9.
23. Das A, Rai D, Dikshit M, Palit G and Nath C. Nature of stress: Differential effects on brain acetylcholinesterase activity and memory in rats. Life Sci. (2005) 77: 2299-311.
24. Moshtaghie AA; Afrang M; Mesripour M. Changes in catecholamines and acetylcholinesterase levels of crebellum, mid-brain and brain cortex in chromium treated rats. Iranian J. Pharm. Res. (2004) 3: 149-153